18th Annual BHIVA Conference, 18-20 April 2012, UK

1 June 2012. Related: Conference reports, BHIVA 18th Birmingham 2012, Conference index.

This year the BHIVA spring conference was held in Birmingham and as usual it included both important national research and impressive international speakers.

In addition to more than 40 oral presentations, the meeting included case studies and over 230 posters.

The selection of reports below only highlights some of these studies. For further details please see the full programme and contact the researchers directly.

The abstracts from the conference are available free online as a PDF supplement to the April edition of HIV Medicine.

http://onlinelibrary.wiley.com/doi/10.1111/hiv.2012.13.issue-s1/issuetoc

This year, BHIVA have done a particularly good job at making the conference available online. Most lectures, presentations and oral sessions are available as webcasts and most, if not all, slides can be viewed or downloaded from the conference website, together with a large proportion of posters.

http://www.bhiva.org/AnnualConference2012.aspx

Reports in this issue include:

• Half of gay men in London interested in daily PrEP to reduce risk of HIV
• Recent infection is common in UK; 30% gay men aged 15-25 infected within a year of diagnosis
• One third of HIV positive people at five UK clinics have symptomatic depression: link to adherence and viral suppression – 40% cases are untreated
• Hodgkin’s lymphoma: survival normalises to HIV negative rates despite more advanced disease at diagnosis
• Promising outcomes from laser ablative treatment of AIN 2/3 to prevent anal cancer
• KS in the HAART era includes patients with high CD4 and suppressed viral load: importance of KS chemotherapy for some patients in addition to ART
• 3rd vs 4th generation HIV testing: almost half of UK clinics out of step with national guidelines
• Case reports of complications from ketamine use in two MSM on ritonavir-based combinations
• Intranasal and topical corticosteroids and risk of Cushing’s symptoms in HIV patients on ritonavir-based combinations
• Outcomes from switches to atazanavir/r in London
• Intimate partner violence towards HIV positive women in the UK